Bo Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bo Cheng has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Daoqiang Zhang
Nanjing University of Aeronautics and Astronautics, Nanjing, China
6 shared publications - Dinggang Shen
ShanghaiTech University
6 shared publications Mingxia Liu
Department of Computer Science and Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing, 210016, China
3 shared publicationsAlzheimer’s Disease Neuroimaging Initiative
1 shared publicationBingli Zhu
College of Computer Science and Engineering, Chongqing Three Gorges University, Chongqing, China
1 shared publicationBrent C. Munsell
College of Charleston
1 shared publication
Latest Publications
- 12 September 2021
- Published by Springer Nature in Neurological Sciences
- Vol. 43 (3) , 1721-1739
Multi-auxiliary domain transfer learning for diagnosis of MCI conversion
In the early stage of Alzheimer’s disease (AD), mild cognitive impairment (MCI) has a higher risk of progression to AD, so the prediction of whether an MCI subject will progress to AD (known as progressive MCI, PMCI) or not (known as stable MCI, SMCI) within a certain period is particularly important in practice. It is known that such a task could benefit from jointly learning-related auxiliary tasks such as differentiating AD from PMCI or PMCI from normal control (NC) in order to take full advantage of their shared commonality. However, few existing methods along this line fully consider the correlations between the target and auxiliary tasks according to the clinical practice of AD pathology for diagnosis. To deal with this problem, in this paper, treating each task domain as a different one, we borrow the idea from transfer learning and propose a novel multi-auxiliary domain transfer learning (MaDTL) method, which explicitly utilizes the correlations between the target domain (task) and multi-auxiliary domains (tasks) according to the clinical practice. Specifically, the proposed MaDTL method incorporates two key modules. The first one is a multi-auxiliary domain transfer-based feature selection (MaDTFS) model, which can select a discriminative feature subset shared by the target domain and the multi-auxiliary domains. In the MaDTFS model, to combine more training data from multi-auxiliary domains and simultaneously suppress the negative effects resulting from the irrelevant parts of multi-auxiliary domains, we proposed a sparse group correlation Lasso that includes a proposed group correlation Lasso penalty (i.e., \({\Vert \mathbf{W}\mathbf{H}\Vert }_{\mathrm{2,1}}\)) and a proposed correlation Lasso penalty (i.e., \({\Vert \mathbf{W}\mathbf{H}\Vert }_{\mathrm{1,1}}\)). The second module in MaDTL is a multi-auxiliary domain transfer-based classification (MaDTC) model that improves the voting with linear weighting-based ensemble learning. This model extends the constraints of the linear weighting method so that it can simultaneously combine training data from multi-auxiliary domains and achieve a robust classifier by minimizing negative effects from the irrelevant part of multi-auxiliary domains. Experimental results on 409 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database with the baseline magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) data validate the effectiveness of the proposed method by significantly improving the classification accuracy to 80.37% for the identification of MCI-to-AD conversion, outperforming the state-of-the-art methods.- 12 September 2021
- Published by Springer Nature in Neurological Sciences
- Vol. 43 (3) , 1721-1739
Multi-auxiliary domain transfer learning for diagnosis of MCI conversion
In the early stage of Alzheimer’s disease (AD), mild cognitive impairment (MCI) has a higher risk of progression to AD, so the prediction of whether an MCI subject will progress to AD (known as progressive MCI, PMCI) or not (known as stable MCI, SMCI) within a certain period is particularly important in practice. It is known that such a task could benefit from jointly learning-related auxiliary tasks such as differentiating AD from PMCI or PMCI from normal control (NC) in order to take full advantage of their shared commonality. However, few existing methods along this line fully consider the correlations between the target and auxiliary tasks according to the clinical practice of AD pathology for diagnosis. To deal with this problem, in this paper, treating each task domain as a different one, we borrow the idea from transfer learning and propose a novel multi-auxiliary domain transfer learning (MaDTL) method, which explicitly utilizes the correlations between the target domain (task) and multi-auxiliary domains (tasks) according to the clinical practice. Specifically, the proposed MaDTL method incorporates two key modules. The first one is a multi-auxiliary domain transfer-based feature selection (MaDTFS) model, which can select a discriminative feature subset shared by the target domain and the multi-auxiliary domains. In the MaDTFS model, to combine more training data from multi-auxiliary domains and simultaneously suppress the negative effects resulting from the irrelevant parts of multi-auxiliary domains, we proposed a sparse group correlation Lasso that includes a proposed group correlation Lasso penalty (i.e., \({\Vert \mathbf{W}\mathbf{H}\Vert }_{\mathrm{2,1}}\)) and a proposed correlation Lasso penalty (i.e., \({\Vert \mathbf{W}\mathbf{H}\Vert }_{\mathrm{1,1}}\)). The second module in MaDTL is a multi-auxiliary domain transfer-based classification (MaDTC) model that improves the voting with linear weighting-based ensemble learning. This model extends the constraints of the linear weighting method so that it can simultaneously combine training data from multi-auxiliary domains and achieve a robust classifier by minimizing negative effects from the irrelevant part of multi-auxiliary domains. Experimental results on 409 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database with the baseline magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) data validate the effectiveness of the proposed method by significantly improving the classification accuracy to 80.37% for the identification of MCI-to-AD conversion, outperforming the state-of-the-art methods.- 7 December 2016
- Published by Springer Nature in Neuroinformatics
- Vol. 15 (2) , 115-132
Multi-Domain Transfer Learning for Early Diagnosis of Alzheimer’s Disease
Recently, transfer learning has been successfully applied in early diagnosis of Alzheimer’s Disease (AD) based on multi-domain data. However, most of existing methods only use data from a single auxiliary domain, and thus cannot utilize the intrinsic useful correlation information from multiple domains. Accordingly, in this paper, we consider the joint learning of tasks in multi-auxiliary domains and the target domain, and propose a novel Multi-Domain Transfer Learning (MDTL) framework for early diagnosis of AD. Specifically, the proposed MDTL framework consists of two key components: 1) a multi-domain transfer feature selection (MDTFS) model that selects the most informative feature subset from multi-domain data, and 2) a multi-domain transfer classification (MDTC) model that can identify disease status for early AD detection. We evaluate our method on 807 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database using baseline magnetic resonance imaging (MRI) data. The experimental results show that the proposed MDTL method can effectively utilize multi-auxiliary domain data for improving the learning performance in the target domain, compared with several state-of-the-art methods.
- 7 December 2016
- Published by Springer Nature in Neuroinformatics
- Vol. 15 (2) , 115-132
Multi-Domain Transfer Learning for Early Diagnosis of Alzheimer’s Disease
Recently, transfer learning has been successfully applied in early diagnosis of Alzheimer’s Disease (AD) based on multi-domain data. However, most of existing methods only use data from a single auxiliary domain, and thus cannot utilize the intrinsic useful correlation information from multiple domains. Accordingly, in this paper, we consider the joint learning of tasks in multi-auxiliary domains and the target domain, and propose a novel Multi-Domain Transfer Learning (MDTL) framework for early diagnosis of AD. Specifically, the proposed MDTL framework consists of two key components: 1) a multi-domain transfer feature selection (MDTFS) model that selects the most informative feature subset from multi-domain data, and 2) a multi-domain transfer classification (MDTC) model that can identify disease status for early AD detection. We evaluate our method on 807 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database using baseline magnetic resonance imaging (MRI) data. The experimental results show that the proposed MDTL method can effectively utilize multi-auxiliary domain data for improving the learning performance in the target domain, compared with several state-of-the-art methods.
- 2 March 2015
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 62 (7) , 1805-1817
Domain Transfer Learning for MCI Conversion Prediction
Machine learning methods have successfully been used to predict the conversion of mild cognitive impairment (MCI) to Alzheimer's disease (AD), by classifying MCI converters (MCI-C) from MCI nonconverters (MCI-NC). However, most existing methods construct classifiers using data from one particular target domain (e.g., MCI), and ignore data in other related domains (e.g., AD and normal control (NC)) that may provide valuable information to improve MCI conversion prediction performance. To address is limitation, we develop a novel domain transfer learning method for MCI conversion prediction, which can use data from both the target domain (i.e., MCI) and auxiliary domains (i.e., AD and NC). Specifically, the proposed method consists of three key components: 1) a domain transfer feature selection component that selects the most informative feature-subset from both target domain and auxiliary domains from different imaging modalities; 2) a domain transfer sample selection component that selects the most informative sample-subset from the same target and auxiliary domains from different data modalities; and 3) a domain transfer support vector machine classification component that fuses the selected features and samples to separate MCI-C and MCI-NC patients. We evaluate our method on 202 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) that have MRI, FDG-PET, and CSF data. The experimental results show the proposed method can classify MCI-C patients from MCI-NC patients with an accuracy of 79.4%, with the aid of additional domain knowledge learned from AD and NC.
- 2 March 2015
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 62 (7) , 1805-1817
Domain Transfer Learning for MCI Conversion Prediction
Machine learning methods have successfully been used to predict the conversion of mild cognitive impairment (MCI) to Alzheimer's disease (AD), by classifying MCI converters (MCI-C) from MCI nonconverters (MCI-NC). However, most existing methods construct classifiers using data from one particular target domain (e.g., MCI), and ignore data in other related domains (e.g., AD and normal control (NC)) that may provide valuable information to improve MCI conversion prediction performance. To address is limitation, we develop a novel domain transfer learning method for MCI conversion prediction, which can use data from both the target domain (i.e., MCI) and auxiliary domains (i.e., AD and NC). Specifically, the proposed method consists of three key components: 1) a domain transfer feature selection component that selects the most informative feature-subset from both target domain and auxiliary domains from different imaging modalities; 2) a domain transfer sample selection component that selects the most informative sample-subset from the same target and auxiliary domains from different data modalities; and 3) a domain transfer support vector machine classification component that fuses the selected features and samples to separate MCI-C and MCI-NC patients. We evaluate our method on 202 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) that have MRI, FDG-PET, and CSF data. The experimental results show the proposed method can classify MCI-C patients from MCI-NC patients with an accuracy of 79.4%, with the aid of additional domain knowledge learned from AD and NC.
- 22 February 2015
- Published by Springer Nature in Brain Imaging and Behavior
- Vol. 9 (4) , 913-926
Multimodal manifold-regularized transfer learning for MCI conversion prediction
As the early stage of Alzheimer’s disease (AD), mild cognitive impairment (MCI) has high chance to convert to AD. Effective prediction of such conversion from MCI to AD is of great importance for early diagnosis of AD and also for evaluating AD risk pre-symptomatically. Unlike most previous methods that used only the samples from a target domain to train a classifier, in this paper, we propose a novel multimodal manifold-regularized transfer learning (M2TL) method that jointly utilizes samples from another domain (e.g., AD vs. normal controls (NC)) as well as unlabeled samples to boost the performance of the MCI conversion prediction. Specifically, the proposed M2TL method includes two key components. The first one is a kernel-based maximum mean discrepancy criterion, which helps eliminate the potential negative effect induced by the distributional difference between the auxiliary domain (i.e., AD and NC) and the target domain (i.e., MCI converters (MCI-C) and MCI non-converters (MCI-NC)). The second one is a semi-supervised multimodal manifold-regularized least squares classification method, where the target-domain samples, the auxiliary-domain samples, and the unlabeled samples can be jointly used for training our classifier. Furthermore, with the integration of a group sparsity constraint into our objective function, the proposed M2TL has a capability of selecting the informative samples to build a robust classifier. Experimental results on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database validate the effectiveness of the proposed method by significantly improving the classification accuracy of 80.1 % for MCI conversion prediction, and also outperforming the state-of-the-art methods.
- 22 February 2015
- Published by Springer Nature in Brain Imaging and Behavior
- Vol. 9 (4) , 913-926
Multimodal manifold-regularized transfer learning for MCI conversion prediction
As the early stage of Alzheimer’s disease (AD), mild cognitive impairment (MCI) has high chance to convert to AD. Effective prediction of such conversion from MCI to AD is of great importance for early diagnosis of AD and also for evaluating AD risk pre-symptomatically. Unlike most previous methods that used only the samples from a target domain to train a classifier, in this paper, we propose a novel multimodal manifold-regularized transfer learning (M2TL) method that jointly utilizes samples from another domain (e.g., AD vs. normal controls (NC)) as well as unlabeled samples to boost the performance of the MCI conversion prediction. Specifically, the proposed M2TL method includes two key components. The first one is a kernel-based maximum mean discrepancy criterion, which helps eliminate the potential negative effect induced by the distributional difference between the auxiliary domain (i.e., AD and NC) and the target domain (i.e., MCI converters (MCI-C) and MCI non-converters (MCI-NC)). The second one is a semi-supervised multimodal manifold-regularized least squares classification method, where the target-domain samples, the auxiliary-domain samples, and the unlabeled samples can be jointly used for training our classifier. Furthermore, with the integration of a group sparsity constraint into our objective function, the proposed M2TL has a capability of selecting the informative samples to build a robust classifier. Experimental results on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database validate the effectiveness of the proposed method by significantly improving the classification accuracy of 80.1 % for MCI conversion prediction, and also outperforming the state-of-the-art methods.
- 31 October 2013
- Published by Springer Nature
- p. 3-32
Brain Disease Classification and Progression Using Machine Learning Techniques
- 31 October 2013
- Published by Springer Nature
- p. 3-32
Brain Disease Classification and Progression Using Machine Learning Techniques
- 16 March 2013
- Published by Springer Nature in Neuroinformatics
- Vol. 11 (3) , 339-353
Semi-Supervised Multimodal Relevance Vector Regression Improves Cognitive Performance Estimation from Imaging and Biological Biomarkers
Accurate estimation of cognitive scores for patients can help track the progress of neurological diseases. In this paper, we present a novel semi-supervised multimodal relevance vector regression (SM-RVR) method for predicting clinical scores of neurological diseases from multimodal imaging and biological biomarker, to help evaluate pathological stage and predict progression of diseases, e.g., Alzheimer’s diseases (AD). Unlike most existing methods, we predict clinical scores from multimodal (imaging and biological) biomarkers, including MRI, FDG-PET, and CSF. Considering that the clinical scores of mild cognitive impairment (MCI) subjects are often less stable compared to those of AD and normal control (NC) subjects due to the heterogeneity of MCI, we use only the multimodal data of MCI subjects, but no corresponding clinical scores, to train a semi-supervised model for enhancing the estimation of clinical scores for AD and NC subjects. We also develop a new strategy for selecting the most informative MCI subjects. We evaluate the performance of our approach on 202 subjects with all three modalities of data (MRI, FDG-PET and CSF) from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. The experimental results show that our SM-RVR method achieves a root-mean-square error (RMSE) of 1.91 and a correlation coefficient (CORR) of 0.80 for estimating the MMSE scores, and also a RMSE of 4.45 and a CORR of 0.78 for estimating the ADAS-Cog scores, demonstrating very promising performances in AD studies.
- 16 March 2013
- Published by Springer Nature in Neuroinformatics
- Vol. 11 (3) , 339-353
Semi-Supervised Multimodal Relevance Vector Regression Improves Cognitive Performance Estimation from Imaging and Biological Biomarkers
Accurate estimation of cognitive scores for patients can help track the progress of neurological diseases. In this paper, we present a novel semi-supervised multimodal relevance vector regression (SM-RVR) method for predicting clinical scores of neurological diseases from multimodal imaging and biological biomarker, to help evaluate pathological stage and predict progression of diseases, e.g., Alzheimer’s diseases (AD). Unlike most existing methods, we predict clinical scores from multimodal (imaging and biological) biomarkers, including MRI, FDG-PET, and CSF. Considering that the clinical scores of mild cognitive impairment (MCI) subjects are often less stable compared to those of AD and normal control (NC) subjects due to the heterogeneity of MCI, we use only the multimodal data of MCI subjects, but no corresponding clinical scores, to train a semi-supervised model for enhancing the estimation of clinical scores for AD and NC subjects. We also develop a new strategy for selecting the most informative MCI subjects. We evaluate the performance of our approach on 202 subjects with all three modalities of data (MRI, FDG-PET and CSF) from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. The experimental results show that our SM-RVR method achieves a root-mean-square error (RMSE) of 1.91 and a correlation coefficient (CORR) of 0.80 for estimating the MMSE scores, and also a RMSE of 4.45 and a CORR of 0.78 for estimating the ADAS-Cog scores, demonstrating very promising performances in AD studies.
- Open Access
- 1 January 2012
- Published by Springer Nature
- Vol. 15, 82-90
Domain Transfer Learning for MCI Conversion Prediction
In recent studies of Alzheimer’s disease (AD), it has increasing attentions in identifying mild cognitive impairment (MCI) converters (MCI-C) from MCI non-converters (MCI-NC). Note that MCI is a prodromal stage of AD, with possibility to convert to AD. Most traditional methods for MCI conversion prediction learn information only from MCI subjects (including MCI-C and MCI-NC), not from other related subjects, e.g., AD and normal controls (NC), which can actually aid the classification between MCI-C and MCI-NC. In this paper, we propose a novel domain-transfer learning method for MCI conversion prediction. Different from most existing methods, we classify MCI-C and MCI-NC with aid from the domain knowledge learned with AD and NC subjects as auxiliary domain to further improve the classification performance. Our method contains two key components: (1) the cross-domain kernel learning for transferring auxiliary domain knowledge, and (2) the adapted support vector machine (SVM) decision function construction for cross-domain and auxiliary domain knowledge fusion. Experimental results on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database show that the proposed method can significantly improve the classification performance between MCI-C and MCI-NC, with aid of domain knowledge learned from AD and NC subjects.
- 1 January 2012
- Published by Springer Nature
- Vol. 15, 82-90
Open AccessDomain Transfer Learning for MCI Conversion Prediction
In recent studies of Alzheimer’s disease (AD), it has increasing attentions in identifying mild cognitive impairment (MCI) converters (MCI-C) from MCI non-converters (MCI-NC). Note that MCI is a prodromal stage of AD, with possibility to convert to AD. Most traditional methods for MCI conversion prediction learn information only from MCI subjects (including MCI-C and MCI-NC), not from other related subjects, e.g., AD and normal controls (NC), which can actually aid the classification between MCI-C and MCI-NC. In this paper, we propose a novel domain-transfer learning method for MCI conversion prediction. Different from most existing methods, we classify MCI-C and MCI-NC with aid from the domain knowledge learned with AD and NC subjects as auxiliary domain to further improve the classification performance. Our method contains two key components: (1) the cross-domain kernel learning for transferring auxiliary domain knowledge, and (2) the adapted support vector machine (SVM) decision function construction for cross-domain and auxiliary domain knowledge fusion. Experimental results on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database show that the proposed method can significantly improve the classification performance between MCI-C and MCI-NC, with aid of domain knowledge learned from AD and NC subjects.